John Alexander Kelly insider trades

Open-market stock purchases and sales by John Alexander Kelly, Chief Financial Officer at Precision Biosciences Inc, from SEC Form 4 filings since Oct 24, 2013.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +48%.

Recent trades

DateStockTradeValue
Jun 1, 2026DTIL Precision Biosciences IncBought (not open market)—
Feb 18, 2026DTIL Precision Biosciences IncSold$31.3K
Feb 17, 2026DTIL Precision Biosciences IncBought (not open market)—
Jan 21, 2026DTIL Precision Biosciences IncSold$61.3K
Jan 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Jan 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Jan 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Nov 3, 2025DTIL Precision Biosciences IncSold$8.5K
Nov 2, 2025DTIL Precision Biosciences IncBought (not open market)—

Companies traded

  • DTIL Precision Biosciences Inc: 8 buys, 4 sales, last Jun 1, 2026
  • FRX Forest Laboratories, LLC: other filings, last Jul 1, 2014

Get free alerts when John Alexander Kelly files a new trade →